Ammi majus Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Umbelliferae; Apiaceae. |
| Habitat | Cultivated in Jammu and Himachal Pradesh. |
| English | Biship’s Weed-Amee, Greater Ammi. |
| Unani | Itarilaal, Khalah. |
| Action | Source of xanthotoxin, a drug employed in the treatment of leucoderma. Dried fruit powder or extract of the plant is used topically in vitiligo. |
| Taxonomic Cohort | Genus Ammi (2 documented species); Family Umbelliferae (42 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Ammi majus (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Umbelliferae; Apiaceae (primary family classification: Umbelliferae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Cultivated in Jammu and Himachal Pradesh.
Across classical and vernacular Indian systems of medicine, Ammi majus is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Biship’s Weed-Amee, Greater Ammi; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Itarilaal, Khalah. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Ammi majus are: Source of xanthotoxin, a drug employed in the treatment of leucoderma. Dried fruit powder or extract of the plant is used topically in vitiligo. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Ammi majus establish the following evidence base: The fruits contain ammoidin (xanthotoxin), ammidin (imperatorin) and majudin (bergapten). All the three compounds are used in leucoderma. Maximum xanthotoxin content (1%) is found in green fruits from Jammu. The 8-MOP, methoxypsoralen constituent of the weed is one of the first agents used along with UVA radiation to treat psoriasis. (Natural Medicines Comprehensive Database, 2007.)

Botanical Reference 1: Ammi majus — Botanical specimen

Botanical Reference 2: Ammi majus — Botanical specimen

Botanical Reference 3: Ammi majus — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Ammi comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Ammi visnaga (Action: Antispasmodic in renal colic, bronchial asthma, whooping cough (used by Unani…). Comparing Ammi majus alongside its congeners in genus Ammi highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Umbelliferae encompasses 42 documented medicinal species (2.32% of the 1,814-species flora). Other representative medicinal members of Umbelliferae include: Ammi visnaga (Khella), Anethum sowa (Shataahvaa. Shatapushpaa), Angelica archangelica himalaica (Chandaa), Angelica glauca (Choraka), Apium graveolens (Ajmodaa). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 42 medicinal species of family Umbelliferae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Ammi majus follow the plant-part modalities specified under its therapeutic action (Source of xanthotoxin, a drug employed in the treatment of leucoderma. Dried fruit powder or extract of the plant is used topically in vitiligo), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Ammi majus integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.